NCT03634176

Brief Summary

Measurement of the diameter of the sheath of the optic nerve in patients hospitalized in intensive care, with increased intracranial pressure (\> 20mmHg) as a substitute measure for diagnosis and follow-up before and after different non-invasive strategies. Three groups were created in which, through strategies already proven and non-invasive (mannitol, hypertonic solution 7.5% NaCl, reverse trendelenburg) to decrease the intracranial pressure, the optic nerve diameter measurement was performed and simultaneously the investigators monitored intracranial pressure through an intraventricular catheter continuously to determine if both correspond

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 16, 2018

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
Last Updated

November 8, 2018

Status Verified

November 1, 2018

Enrollment Period

1.6 years

First QC Date

August 11, 2018

Last Update Submit

November 6, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Optic nerve sheet diameter

    The optic nerve sheet diameter in each eye was measured vertically and horizontally 3 mm behind the optic disc, with the two values averaged

    immediately before administering the treatment according to the group and every 30 minutes after administering the treatment until 90 min.

Study Arms (3)

Group M

both optic nerve sheath diameter (the posterior 3mm of the papilla) before and after received 0.5gr/kg 20% mannitol

Diagnostic Test: optical nerve sheet diameter

Group H

both optic nerve sheath diameter (the posterior 3mm of the papilla) before and after received 1.5 ml/kg 7.5% NaCl solution

Diagnostic Test: optical nerve sheet diameter

Group P

both optic nerve sheath diameter (the posterior 3mm of the papilla) before and after patients were positioned on reverse Trendelenburg position 30 degrees higher than the feet

Diagnostic Test: optical nerve sheet diameter

Interventions

The ONSD in each eye was measured vertically and horizontally 3 mm behind the optic disc, with the two values averaged. No pressure was applied to the orbit. At each time point, measurements were taken within 5 min. The measurements were made before (T1) and after some of the strategies according to group 30 min (T2), 60 min (T3), and 90 min (T4).

Group HGroup MGroup P

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalized in the intensive care unit of the Dr. Migel Pérez Carreño hospital with increased intracranial pressure of traumatic or non-traumatic etiology.

You may qualify if:

  • Adult patients (≥ 18 years old) with traumatic or non-traumatic elevated ICP (defined as greater than 20 mm Hg for at least 10min)
  • Hospitalized in ICU
  • Patients with ICP continuous measurement through an intraventricular catheter
  • Respiratory rate maintained at 10-18 breaths/min to maintain the end tidal carbon dioxide partial pressure between 35 and 40 mmHg
  • Peak airway pressure \<35 cmH2O
  • Positive end-expiratory pressure \<5 cmH2O

You may not qualify if:

  • Patients who had undergone cranial decompression surgery
  • Patients with ocular pathology
  • Patients who had previously undergone eye surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Dr Miguel Perez Carreño

Caracas, Venezuela, Bolivarian Republic of, 1020, Venezuela

Location

MeSH Terms

Conditions

Intracranial Hypertension

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, anesthesiologist.

Study Record Dates

First Submitted

August 11, 2018

First Posted

August 16, 2018

Study Start

February 1, 2017

Primary Completion

August 30, 2018

Study Completion

September 30, 2018

Last Updated

November 8, 2018

Record last verified: 2018-11

Locations